Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder

NCT04466345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

BIOLOGICAL: Semaglutide
BIOLOGICAL: Placebo

Sponsor

University Health Network, Toronto